Hematologic Malignancy | sciencenewsnet.in

Breaking News

A Scientific Method for Startups

Four Approaches to New Venture Creation: Taking Stock and Moving Forward

Research update: Chalk-coated textiles cool in urban environments

New material to make next generation of electronics faster and more efficient

Curious by Nature: Dr. Neil Johnson – Hate Groups After Elections

Distinguished Lecture by Nobel Laureate, Prof. Jean-Marie Lehn

Distinguished Lecture: Targeting a World-Leading Market Supplier of Graphene Materials

University of Idaho researcher uncovers surprising way to stop beer from exploding

Cedars-Sinai Experts Available to Discuss Healthy Aging During GSA 2024

Novel Pulmonary Valve Aims to Reduce Invasive Surgeries for Kids

08 Nov, 2024

Latest Blood Cancer Treatment Updates Presented at Annual NCCN Event During Blood Cancer Awareness Month

September 18, 2023 sarah JonasAnnouncement

NCCN 2023 Annual Congress: Hematologic Malignancies features expert perspectives on developments in blood cancer treatment, including NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Updates, CAR T-Cell therapy, BTK Inhibitors, Bispecific T-Cell Engagers, and More. The live event is taking place September 22-23, 2023, at the Hilton San Francisco Union Square.